These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11545498)

  • 21. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
    Vaidyanathan G; Zalutsky MR
    Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice.
    Beck R; Seidl C; Pfost B; Morgenstern A; Bruchertseifer F; Baum H; Schwaiger M; Senekowitsch-Schmidtke R
    Cancer Sci; 2007 Aug; 98(8):1215-22. PubMed ID: 17561973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy with alpha-emitting nuclides.
    McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
    Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
    Featherstone C
    Mol Med Today; 1997 Jun; 3(6):232-3. PubMed ID: 9211409
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeted alpha therapy with 213Bi.
    Morgenstern A; Bruchertseifer F; Apostolidis C
    Curr Radiopharm; 2011 Oct; 4(4):295-305. PubMed ID: 22202152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoconjugates for targeted alpha therapy of malignant melanoma.
    Abbas Rizvi SM; Sarkar S; Goozee G; Allen BJ
    Melanoma Res; 2000 Jun; 10(3):281-9. PubMed ID: 10890383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
    Vandenbulcke K; De Vos F; Offner F; Philippé J; Apostolidis C; Molinet R; Nikula TK; Bacher K; de Gelder V; Vral A; Lahorte C; Thierens H; Dierckx RA; Slegers G
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1357-64. PubMed ID: 12845484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
    Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
    Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death.
    Seidl C; Schröck H; Seidenschwang S; Beck R; Schmid E; Abend M; Becker KF; Apostolidis C; Nikula TK; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):274-85. PubMed ID: 15791436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells.
    Kennel SJ; Stabin M; Roeske JC; Foote LJ; Lankford PK; Terzaghi-Howe M; Patterson H; Barkenbus J; Popp DM; Boll R; Mirzadeh S
    Radiat Res; 1999 Mar; 151(3):244-56. PubMed ID: 10073661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy.
    Fani M; Vranjes S; Archimandritis SC; Potamianos S; Xanthopoulos S; Bouziotis P; Varvarigou AD
    Appl Radiat Isot; 2002 Nov; 57(5):665-74. PubMed ID: 12433040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206.
    Abbas Rizvi SM; Song EY; Raja C; Beretov J; Morgenstern A; Apostolidis C; Russell PJ; Kearsley JH; Abbas K; Allen BJ
    Cancer Biol Ther; 2008 Oct; 7(10):1547-54. PubMed ID: 18708762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer radioimmunotherapy with alpha-emitting nuclides.
    Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
    Allen BJ
    Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications.
    Hassfjell S; Brechbiel MW
    Chem Rev; 2001 Jul; 101(7):2019-36. PubMed ID: 11710239
    [No Abstract]   [Full Text] [Related]  

  • 39. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
    Radchenko V; Morgenstern A; Jalilian AR; Ramogida CF; Cutler C; Duchemin C; Hoehr C; Haddad F; Bruchertseifer F; Gausemel H; Yang H; Osso JA; Washiyama K; Czerwinski K; Leufgen K; Pruszyński M; Valzdorf O; Causey P; Schaffer P; Perron R; Maxim S; Wilbur DS; Stora T; Li Y
    J Nucl Med; 2021 Nov; 62(11):1495-1503. PubMed ID: 34301779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.